Cost-effectiveness analysis in clinical practice: The case of heart failure

Archives of Internal Medicine

Volumn 159, Issue 15, 1999, Pages 1690-1700

  Rich, Michael W ^a   Nease, Robert F ^a  

^a BARNES JEWISH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; ENALAPRIL MALEATE; HYDRALAZINE; ISOSORBIDE DINITRATE; MILRINONE;

BEHAVIOR MODIFICATION; CLINICAL PRACTICE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DIET THERAPY; DRUG COST; EXERCISE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE FINANCING; HEART FAILURE; HOME CARE; HOSPITAL COST; HOSPITALIZATION; HUMAN; NOMENCLATURE; OUTCOMES RESEARCH; PATIENT COUNSELING; PRIORITY JOURNAL; REVIEW;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CLINICAL MEDICINE; COMBINED MODALITY THERAPY; CONFOUNDING FACTORS (EPIDEMIOLOGY); COST-BENEFIT ANALYSIS; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HOSPITAL CHARGES; HUMANS; PATIENT CARE TEAM; UNITED STATES;

EID: 0033598082     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.159.15.1690     Document Type: Review

References (51)

1. American Heart Association. 1998 Heart and Stroke Statistical Update. Dallas, Tex: American Heart Association; 1998.
2. National Heart Lung and Blood Institute. Congestive Heart Failure in the United States: A New Epidemic. Bethesda, Md: US Dept of Health and Human Services; 1996.
3. Graves EJ, Owings MF. 1995 Summary: National Hospital Discharge Survey. Hyattsville, Md: National Center for Health Statistics; 1997. Advance Data From Vital and Health Statistics, No. 291.
4. Graves EJ. Detailed diagnoses and procedures, National Hospital Discharge Survey, 1990. Vital Health Stat 13. 1992;113:1-225.
5. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant 1994; 13:S107-S112
6. Centers for Disease Control and Prevention. Trends in ischemic heart disease mortality - United States, 1980-1988. MMWR Morb Mortal Wkly Rep. 1992; 41:548-549, 555-556.
7. Centers lor Disease Control and Prevention. Cerebrovascular disease mortality and Medicare hospitalization-United States, 1980-1990. MMWR Morb Mortal Wkly Rep. 1992;41:477-480.
8. Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997;45:968-974.
9. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis for health and medical practices. N Engl J Med. 1977;296:716-721.
10. Weinstein MC, Fineberg HV, Elstein AS, et al. Clinical Decision Analysis. Philadelphia, Pa: WB Saunders Co; 1980.
11. Kamlet MS. The Comparative Benefits Modeling Project: A Framework for Cost-Utility Analysis of Government Health Care Programs. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1992.
12. Patrick DL, Erickson P. Health Status and Health Policy: Quality of Life in Health Care Evaluation and Resource Allocation. New York, NY: Oxford University Press; 1993.
13. Spilker B. Quality of Life Assessment in Clinical Trials. New York, NY: Raven Press; 1990.
14. Eisenberg JM. Clinical economics: a guide to the economic analysis of clinical practices. JAMA. 1989;262:2879-2886.
15. Luce BR, Manning WG, Siegel JE, Lipscomb J. Estimating costs in cost-effectiveness analysis. In: Gold MR, Siegel JE, Russell LB, Weinstein MC, eds. Cost-effectiveness in Health and Medicine. New York, NY: Oxford University Press; 1996:176-213.
16. Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102-109.
17. Goldman L, Gordon DJ, Rifkind BM, et al. Cost and health implications of cholesterol lowering. Circulation. 1992;85:1960-1968.
18. Konstam M, Dracup K, Baker D, et al. Heart Failure: Evaluation and Care of Patients With Left Ventricular Systolic Dysfunction: Clinical Practice Guideline No. 11. Rockville, Md: Agency for Health Care Policy and Research; 1994. Publication AH-CPR 94-0612.
19. Paul SD, Kuntz KM, Eagle KA, Weinstein MC. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med. 1994;154:1143-1149.
20. Butler JRG, Fletcher PJ. A cost-effectiveness analysis of enalapril maleate in the management of congestive heart failure in Australia. Aust N Z J Med. 1996;26:89-95.
21. Kleber FX. Socioeconomic aspects of ACE inhibition in the secondary prevention in cardiovascular diseases. Am J Hypertens. 1994;7:112S-116S.
22. Tsevat J, Duke D, Goldman L, et al. Cost-effectiveness of captopril therapy after myocardial infarction. J Am Coll Cardiol. 1995;26: 914-919.
23. Ward RE, Gheorghiade M, Young JB, Uretsky B. Economic outcomes of withdrawal of digoxin therapy in adult patients with stable congestive heart failure. J Am Coll Cardiol. 1995;26:93-101.
24. DeleaTE, Vera-Llonch M, Richner RE, Fowler MB, Oster G. Cost-effectiveness of carvedilol for heart failure. Am J Cardiol. 1999;83:890-896.
25. Marius-Nunez AL, Heaney L, Fernandez RN, et al. Intermittent inotropic therapy in an outpatient setting: a cost-effective therapeutic modality in patients with refractory heart failure. Am Heart J. 1996;132:805-808.
26. Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. N Engl J Med. 1986; 314:1547-1552.
27. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-310.
28. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular election fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
29. Hart W, Rhodes G, McMurray J. The cost effectiveness of enalapril in the treatment of chronic heart failure. Br J Med Econ. 1993;6:91-98.
30. Kleber FX, Niernoller L, Doering W. Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial. Br Heart J. 1992;67:289-296.
31. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial. N Engl J Med. 1992; 327:669-677.
32. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-533.
33. Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol. 1993;22:955-962.
34. Packer M, Gheorghiade M, Young JB, et al. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors: RADIANCE study. N Engl J Med. 1993;329:1-7.
35. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-1355.
36. Vinson JM, Rich MW, Sperry JC, Shah AS, McNamara T. Early readmission of elderly patients with congestive heart failure. J Am Geriatr Soc. 1990;38:1290-1295.
37. Ghali JK, Kadakia S, Cooper R, Ferlinz J. Precipitating factors leading to decompensation of heart failure: traits among urban blacks. Arch Intern Med. 1988;148:2013-2016.
38. Cintron G, Bigas C, Linares E, Aranda JM, Hernandez E. Nurse practitioner role in a chronic congestive heart failure clinic: in-hospital time, costs, and patient satisfaction. Heart Lung. 1983;12: 237-240.
39. Rich MW, Vinson JM, Sperry JC, et al. Prevention of readmission in elderly patients with congestive heart failure: results of a prospective, randomized pilot study. J Gen Intern Med. 1993;8: 585-590.
40. Lasater M. The effect of a nurse-managed CHF clinic on patient readmission and length of stay. Home Healthcare Nurse. 1996;14:351-356.
41. Kostis JB, Rosen RC, Cosgrove DM, Shindler DM, Wilson AC. Nonpharmacologic therapy improves functional and emotional status in congestive heart failure. Chest. 1994;106:996-1001.
42. Kornowski R, Zeeli D, Averbuch M, et al. Intensive home-care surveillance prevents hospitalization and improves morbidity rates among elderly patients with severe congestive heart failure. Am Heart J. 1995;129:762-756.
43. Rich MW, Beckham V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 1995;333:1190-1195.
44. Stewart S, Vandenbroek AJ, Peason S, Horowitz JD. Prolonged beneficial effects of a home-based intervention on unplanned readmissions and mortality among patients with congestive heart failure. Arch Intern Med. 1999;159:257-261.
45. Dennis LI, Blue CL, Stahl SM, Benge ME, Shaw CJ. The relationship between hospital readmissions of Medicare beneficiaries with chronic illnesses and home care nursing interventions. Home Healthcare Nurse. 1996;14:303-309.
46. Martens KH, Mellor SD. A study of the relationship between home care services and hospital readmission of patients with congestive heart failure. Home Healthcare Nurse. 1997;15:123-129.
47. West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997;79:58-63.
48. Fonaraw GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725-732.
49. Rich MW, Gray DB, Beckham V, Wittenberg C, Luther P. Effect of a multidisciplinary intervention on medication compliance in elderly patients with congestive heart failure. Am J Med. 1996;101:270-276.
50. Hogness JR, VanAntwerp M, eds. The Artificial Heart: Prototypes, Policies, and Patients. Washington, DC: National Academy Press; 1991.
51. Evans RW. Cost-effectiveness analysis of transplantation. Surg Clin North Am. 1986;66:603-617.